Pineapple Financial Just Flipped the Script with a $100M Injective Treasury—Here’s Why Every Investor Should Be Alert Right Now
Ever wondered what it takes for a public company to pioneer in the crypto space and actually put its money where its mouth is? Well, Pineapple Financial just threw down a $100 million Injective treasury — making them the first publicly traded company to officially hold INJ tokens. It’s like watching traditional finance tiptoe into the crypto pool, then suddenly cannonball in with style. With a targeted 12% staking yield and backing from a mix of big names across traditional and crypto finance, this move isn’t just bold — it’s a potential game-changer. And with the SEC busy scrutinizing Canary Capital’s staked INJ ETF proposal, the timing couldn’t be more intriguing. Curious to see how this will shake up the digital asset world? LEARN MORE
The NYSE-listed fintech becomes the first public INJ holder with a $100M strategy.
Key Takeaways
- Pineapple Financial raised $100M to build the first Injective treasury by a publicly traded company, aiming for 12% staking yield.
- The news comes as the SEC reviews Canary Capital’s staked Injective ETF application, with INJ trading near $12.8.
Share this article
Pineapple Financial launched a $100 million Injective treasury strategy today, becoming the first publicly listed company to hold INJ tokens. The NYSE American-listed fintech company (PAPL) secured the funding through a private placement.
The treasury aims to generate approximately 12% passive yield through staking, positioning it among the highest returns across major blockchain networks. The initiative attracted investment from both traditional finance and crypto firms, including FalconX, Monarq, Abraxas, Kraken, Blockchain.com, Canary Capital, and the Injective Foundation.
“The launch of the first Injective digital asset treasury represents a defining moment for Injective and its ecosystem,” said Eric Chen, co-founder of Injective.
The announcement comes as Injective draws more attention, with the SEC opening a comment period on Canary Capital’s proposed staked INJ ETF. Filed in July, the application is open for 21 days of feedback and up to 90 days of review. If approved, it would trade on Cboe BZX and track Injective’s token through a staking structure.
INJ jumped 6% on the news to $13.30 before retracing later in the day. The token was last changing hands at $12.80.
Share this article
Post Comment